EFNB1 Acts as a Novel Prognosis Marker in Glioblastoma through Bioinformatics Methods and Experimental Validation
Purpose. Ephrin B1 (EFNB1), the Eph-associated receptor tyrosine kinase ligand, is suggested to have an important function in neurodevelopment. However, its contribution to glioblastoma multiforme (GBM) remains uncertain. This study aimed to determine the prognostic power and immune implication of E...
Guardado en:
Autores principales: | Yaohong Shi, Yuanyuan Sun, Hongyan Cheng, Chen Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b9306f2e69474a2ead6cc1402b661412 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of Hub Genes Correlated With Poor Prognosis for Patients With Uterine Corpus Endometrial Carcinoma by Integrated Bioinformatics Analysis and Experimental Validation
por: Yi Yuan, et al.
Publicado: (2021) -
Novel cancer stem cell marker MVP enhances temozolomide-resistance in glioblastoma
por: Kum Hee Noh, et al.
Publicado: (2022) -
Novel Treatment Strategies for Glioblastoma—A Summary
por: Stanley S. Stylli
Publicado: (2021) -
Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis
por: Ke Gong MBBS, et al.
Publicado: (2021) -
Identification of novel autophagy-related lncRNAs associated with a poor prognosis of colon adenocarcinoma through bioinformatics analysis
por: Dejun Wu, et al.
Publicado: (2021)